BTG completes the acquisition of Galil Medical

London, UK, 15 June 2016

BTG plc (LSE: BTG), the specialist healthcare company, is pleased to announce that it has completed the acquisition of Galil Medical, a leading provider of cryoablation products for the treatment of kidney and other cancers.

BTG announced on 6 May 2016 that it had entered into an agreement to acquire Galil.

For further information contact:

BTG   
Andy Burrows, VP Corporate & Investor Relations
+44 (0)20 7575 1741; Mobile: +44 (0)7990 530 605

Stuart Hunt, Investor Relations Manager
+44 (0)20 7575 1582; Mobile: +44 (0)7815 778 536

Chris Sampson, Corporate Communications Director
+44 20 7575 1595; Mobile: +44 7773 251 178

FTI Consulting
Ben Atwell/Simon Conway
+44 (0)20 3727 1000